How to treat old MCL patients: One size fits it all?

Abstract

In this issue of Blood, Abrahamsson et al have described a real-world scenario for the front-line treatment of mantle cell lymphoma (MCL). Medical knowledge in hematologic malignancies is based on currently available data, preferably from prospective trials; however, these data are limited by recruitment of fit, predominantly younger patients in most trials. Thus, additional data on a more representative patient population, including elderly patients, are urgently needed. © 2014 by The American Society of Hematology.